Cure My Disease

Don't miss your cure!

 Log in / Sign up

Blood test could sharpen lung cancer screening, study says

NCT ID NCT03774758

Recruiting now Diagnosis Sponsor: University of California, San Francisco Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study is testing a blood test that looks for tumor DNA to see if it can more accurately tell whether a lung nodule found on a CT scan is cancer. About 590 people getting lung cancer screening will give blood samples and be followed for 3 years. The goal is to improve how we decide which nodules need further testing, reducing unnecessary procedures.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for NODULE SOLITARY PULMONARY are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

non-small cell lung carcinoma pulmonary coin lesion

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

NODULE SOLITARY PULMONARY NON-SMALL CELL LUNG CANCER

Contacts and locations

Study contacts

  • Contact

    Email: •••••@•••••

Locations

  • San Francisco VA Medical Center

    RECRUITING

    San Francisco, California, 94121, United States

    Contact Email: •••••@•••••

  • University of California, San Francisco

    RECRUITING

    San Francisco, California, 94122, United States

    Contact Email: •••••@•••••

  • Zuckerberg San Francisco General Hospital and Trauma Center

    RECRUITING

    San Francisco, California, 94110, United States

    Contact Email: •••••@•••••

More trials for these conditions

Other studies related to the condition(s) this trial covers.